Free Daily Podcast Summary
from Dreamers to Disruptors: Daily Summaries Delivered
by Medidata
This is a call to the world’s visionaries who made waves. The ones who gave themselves the green light to turn bold dreams into disruptive realities and shake up the status quo. Hear straight from industry leaders across tech, healthcare, and life sciences as they share their stories and innovations with us. This is from Dreamers to Disruptors, a podcast by Medidata.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 2 weeks ago1h 5m
DTRA’s Craig Lipset on Decentralized Trials and Accelerating Rare Disease Research
New technologies have always driven advances in clinical research, and that’s still true today. The Covid pandemic rapidly accelerated the adoption of decentralized trials, powered by emerging health tech, but in less dramatic times, life sciences must find ways to ensure continued innovation.As an industry veteran and co-chair of the Digital Trials & Research Alliance (DTRA), Craig Lipset has a powerful perspective on the potential of emerging technologies, and how to successfully combat inertia and encourage adoption in clinical studies.He joins Medidata CEO Anthony Costello to explore the origins of decentralized trials, the potential of Virtual Twins, and how the Buffalo Initiative is promoting research into understudied rare diseases.Visit our websiteRead our blogFollow Medidata: LinkedIn, Instagram, X, YouTubeFollow Anthony: LinkedInFollow Craig: LinkedIn
- Jun 23, 202656 min
Medidata NEXT London 2026 LIVE
At its heart, Medidata NEXT is a conversation where leading experts in clinical research come together in open dialogue. Representing the biggest names in healthcare and life sciences from around the world, they explore industry challenges and share their excitement for what the future holds.That made NEXT Innovation Day London the perfect venue for our latest live edition of from Dreamers to Disruptors. Recorded straight from the show floor, Medidata leaders and a broad range of guests break down the power and incredible potential of AI across the clinical trial process, combining diverse perspectives into a united vision for the next era of healthcare technology.Session 1 Speakers:Edward Ford | Vice President, Client Engagement, MedidataAnthony Costello | CEO, MedidataNitish Mittal | Partner, Everest GroupKrzysztof Wróblewski | Head of Global Clinical Solutions Technologies, Senior Director, AstraZenecaSession 2 Speakers:Aryana Hosseinkhani | Vice President, Head of Product Marketing, MedidataLisa Moneymaker | Chief Strategy Officer, MedidataChris Standley | Vice President, Vendor Governance, Worldwide Clinical TrialsSession 3 Speakers:Wayne Walker | GM, Head of Data Experience, MedidataRobyn Orie | Sr. Director, Data Innovation, CaidyaCassie Kendrew | Chief Operating Officer, EMS HealthcareAmardeep Heer | Medidata Site Insights Board Member | Principal Investigator, Lakeside HealthcareVisit our websiteRead our blogFollow Medidata: LinkedIn, Instagram, X, YouTube
- May 26, 202639 min
Fighting Cancer with External Control Arms: Friends of Cancer Research’s Jeff Allen
External Control Arms are a powerful clinical research tool, harnessing cutting-edge tech to fill gaps in clinical data and accelerate trials when patients’ lives are on the line. They’re particularly valuable for cancer research, where patients can neither afford to wait nor settle for the current standard of care.Friends of Cancer Research President and CEO Jeff Allen sits down with Medidata CEO Anthony Costello and Senior Vice President, Statistics and Regulatory Science Innovation Ruthie Davi to celebrate 30 years of oncology innovation, and explore what’s coming next.They dig deep into Medidata and Friends’ partnership to bring the power of External Control Arms to pancreatic cancer research, and how to build a future where clinical research takes full advantage of these life-saving innovations.Visit our websiteRead our blogFollow Medidata: LinkedIn, Instagram, X, YouTubeFollow Anthony: LinkedInFollow Jeff: LinkedInFollow Ruthie: LinkedIn
- Mar 30, 20261h 25m
Medidata NEXT New York 2026 LIVE
NEXT New York is our flagship event, bringing together the world’s leading life sciences companies and thinkers to envision a transformative future for healthcare that challenges our preconceptions of what’s possible in clinical trials.This special edition of from Dreamers to Disruptors was recorded live from the show floor at NEXT, capturing the hottest takes and insights from Medidata leaders and special guests. From the end-to-end AI support reshaping studies, to building trust in cutting-edge clinical technologies, our speakers share their fresh perspectives on what matters most to pharma professionals today.Session 1 Speakers:Edward Ford | Vice President, Client Engagement, MedidataAnthony Costello | CEO, MedidataMatteo di Tommaso | Senior Vice President, R&D Business Insights & Technology, Bristol Myers SquibbNimita Limaye | Research Vice President, Life Sciences R&D Strategy and Technology, IDCSession 2 Speakers:Aryana Hosseinkhani | Vice President, Head of Product Marketing, MedidataMeghan Harrington | Vice President, Clinical Trial Financial Management, MedidataPaul O'Donohoe | Senior Director, eCOA Product and Science, MedidataSharlene Carnegie | Senior Vice President, Product and Engineering, MedidataSession 3 Speakers:Jeff Ventimiglia | Senior Vice President, Offering and Portfolio Management, MedidataBryant Fields | Vice President, Partnerships, MedidataRobert Lyons | Vice President, Engineering, MedidataJia Chen | Head, Product, AI, MedidataSession 4 Speakers: Lisa Moneymaker | Senior Vice President, Chief Strategy Officer, MedidataTom Doyle | Senior Vice President, Chief Technology Officer, MedidataClaire Biot | Vice President, Life Sciences and Healthcare Industry, Dassault SystèmesPatrick Johnson | EVP, Corporate Research and Sciences, Dassault SystèmesVisit our websiteRead our blogFollow Medidata: LinkedIn, Instagram, X, YouTube
- Feb 23, 20261h 0m
Investing in the Future of Healthcare: 7wire Ventures’ Lee Shapiro
As a veteran entrepreneur in life sciences, Lee Shapiro has invested in some of the most transformative technologies in modern healthcare history—developing a deep understanding of what makes for truly successful innovation.Medidata CEO Anthony Costello sits down with Lee to discover the secret to his success. Charting his work across a variety of leading life sciences organizations, from Allscripts and Livongo, to Click Therapeutics and Medidata itself, Lee uncovers the qualities that underpin the most accomplished enterprises.Join Lee and Anthony as they paint a powerful picture of our evolving industry and explore the disruptions shaping the future of healthcare.Visit our websiteRead our blogFollow Medidata: LinkedIn, Instagram, X, YouTubeFollow Anthony: LinkedInFollow Lee: LinkedIn
- Jan 26, 202654 min
Life Sciences Innovation in 2026: Predictions and Goals
As we enter the new year, the mandate is clear: evolve clinical research or get left behind.Join us to revisit conversations between Medidata CEO Anthony Costello and some of the leading industry minds—including Every Cure’s David Fajgenbaum, Digital Medicine Society’s Jennifer Goldsack, and Click Therapeutics’ David Klein—as they look to the future of life sciences in 2026 and beyond.From unlocking deeper data insights to scaling radical innovation, our guests issue a direct call to action: harness today’s cutting-edge technology to build a faster, smarter, and healthier world for patients everywhere.Visit our websiteRead our blogFollow Medidata: LinkedIn, Instagram, X, YouTubeFollow Anthony: LinkedIn
- Dec 15, 202548 min
How Drug Repurposing Unlocks New Uses for Existing Medicines: Every Cure’s David Fajgenbaum
David Fajgenbaum’s relationship to drug repurposing is personal, professional, and one of the most inspiring stories in modern medicine. Diagnosed with Castleman disease and running out of treatment options, David used his research skills to identify an existing drug that saved his life.Join David and Medidata CEO Anthony Costello to explore the origins of Every Cure—and how David’s experience became the seed for a nonprofit that uncovers life-changing uses for treatments already approved for other conditions. Discover Every Cure’s innovative approaches to data, the scope of unmet needs across healthcare, and how pharmaceutical companies can contribute to a future where we unlock the full potential of treatments for all.Visit our websiteRead our blogFollow Medidata: LinkedIn, Instagram, X, YouTubeFollow Anthony: LinkedInFollow David: LinkedIn
- Nov 11, 202555 min
The Challenges of Clinical Trial Digitization and The Digital Medicine Society (DiMe) Mission: Jennifer Goldsack
Jennifer Goldsack has made it her mission to push the boundaries of how technology can enhance healthcare. As founder and CEO of the Digital Medicine Society (DiMe), she supports digital innovators exploring new ways to deliver better outcomes for patients everywhere.Jennifer and Medidata CEO Anthony Costello explore how clinical trials once led the way in life sciences digitization, why they’re falling behind, and how we can get our industry back on track.Join them to discover how Jennifer is promoting innovation and making smarter use of clinical data, as well as her personal story of navigating the healthcare system and confronting the everyday challenges patients face.Visit our websiteRead our blogFollow Medidata: LinkedIn, Instagram, X, YouTubeFollow Anthony: LinkedInFollow Jennifer: LinkedIn
About from Dreamers to Disruptors
This is a call to the world’s visionaries who made waves. The ones who gave themselves the green light to turn bold dreams into disruptive realities and shake up the status quo. Hear straight from industry leaders across tech, healthcare, and life sciences as they share their stories and innovations with us. This is from Dreamers to Disruptors, a podcast by Medidata.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from from Dreamers to Disruptors in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's from Dreamers to Disruptors daily summary?
It's a free AI-powered email that summarizes new episodes of from Dreamers to Disruptors as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the from Dreamers to Disruptors podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official from Dreamers to Disruptors product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Medidata.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
How often does from Dreamers to Disruptors release new episodes?
from Dreamers to Disruptors publishes monthly. Our AI generates a summary within hours of each new episode.
What topics does from Dreamers to Disruptors cover?
from Dreamers to Disruptors covers topics including Technology, Medicine, Fitness, Health & Fitness. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting from Dreamers to Disruptors summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.